John Harris - CEO, OBN
John brings to OBN extensive leadership and managerial competence developed within well respected Blue-Chip, Governmental and SME organisations, specialised in the Life Sciences Sectors. Over his 30 years working in this space (including 14 years at CEO level), he has developed considerable experience and expertise within the pharmaceutical and medical technology arenas ranging through research, technical & commercial development, registration, manufacture, marketing, and sales.
Immediately prior to joining OBN he was involved in delivering Business and Export advice to UK Trade & Industry clients, assisting Life Science companies on growth strategies both domestically and abroad and was Managing Partner of Qube Associates, a specialist consultancy focusing on science-based SME’s. Previous appointments include Managing Director of IPS Specials / Vertical Pharma Ltd (a cGMP, MHRA licensed manufacturer of ‘Special’ compounded pharmaceuticals), Managing Director of Key Organics Ltd (a leading manufacturer of chemical intermediates), Managing Director of Synerga Ltd (a start-up drug discovery venture) and Chief Executive Officer of TraceTag International Ltd (a biotech company specialising in the research, development and marketing of hi-tech diagnostics).
Dr Harris holds a BSc (Hons) in Biology from the University of Salford, a PhD in Biochemistry from the University of Southampton and a MBA from the University of Surrey.